a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.
Some practitioners begin patients on the simplified, twice-daily regimen of regular insulin and isophane insulin. In this regimen, the total daily dose is equal to 0.7 unit times the body weight ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
This has been a most successful plan since, on the one hand, it has assured adequate insulin effect early in the day at a time when isophane insulin is least active and, on the other hand ...
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback